| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8228242 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 7 Pages |
Abstract
The combination of poor differentiation and pathologic tumor depth of 4 mm or greater identified a subset of pT1-2N0 OSCC patients with poor outcome, who may have clinical benefit from postoperative adjuvant radiotherapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Chun-Ta M.D., Chien-Yu M.D., Kang-Hsing M.D., Hung-Ming M.D., Shu-Hang M.D., Li-Yu M.D., Chuen M.D., I-How M.D., Shiang-Fu M.D., Chung-Jan M.D., Tzu-Chen M.D, Ph.D.,